WASATCH ADVISORS LP

Position in VKTX — Viking Therapeutics, Inc.

CIK 814133 SALT LAKE CITY, UT

Position in VKTX

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$10,190,161

+$4,371,178 QoQ

Shares Held

313,158

+89.3% QoQ

Ownership

0.270%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

WASATCH ADVISORS LP holds $59,676,298 across 9 Biotechnology names. VKTX ranks #2 (17.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PHAT	Phathom Pharmaceuticals, Inc.	1,340,916	$14,897,576
2	VKTX	Viking Therapeutics, Inc. This page	313,158	$10,190,161
3	DYN	Dyne Therapeutics, Inc.	443,668	$8,043,700
4	CCCC	C4 Therapeutics, Inc.	2,961,761	$7,789,431
5	IMTX	Immatics N.V.	464,823	$4,573,858
6	MGNX	Macrogenics Inc	1,559,701	$4,507,535
7	NTLA	Intellia Therapeutics, Inc.	261,864	$3,357,096
8	NKTX	Nkarta, Inc.	1,577,847	$3,329,257

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,190,161	313,158	+89.3%	Shares	Sole	2026-04-21
2025-12-31	$5,818,983	165,406	+28.8%	Shares	Sole	2026-02-12
2025-09-30	$3,376,112	128,467	-51.0%	Shares	Sole	2025-11-14
2025-06-30	$6,944,192	262,045	+1.8%	Shares	Sole	2025-08-14
2025-03-31	$6,217,369	257,448	+42.3%	Shares	Sole	2025-05-15
2024-12-31	$7,280,140	180,918	-20.6%	Shares	Sole	2025-02-13
2024-09-30	$14,416,953	227,720	-10.1%	Shares	Sole	2024-11-14
2024-06-30	$13,420,488	253,169	-0.9%	Shares	Sole	2024-08-14
2024-03-31	$20,953,952	255,536	-80.0%	Shares	Sole	2024-04-18
2023-12-31	$23,726,726	1,274,945	+32.4%	Shares	Sole	2024-02-14
2023-09-30	$10,663,332	963,264	-43.7%	Shares	Sole	2023-11-14
2023-06-30	$27,710,589	1,709,475	+0.2%	Shares	Sole	2023-08-08
2023-03-31	$28,395,642	1,705,444	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.